March 4: Primer
March 8-9: Conference
DIA is offering a virtual conferencefor the Advertising and Promotion Regulatory Affairs Conference that allows you to view all the session recordings from the comfort of your own home/office. Can't make all the sessions live? You will receive access to the On Demand library with your registration for 2 months post-conference.
DIA’s Advertising and Promotion Regulatory Affairs Conference explores the current state of compliance for marketing both biopharmaceuticals and medical devices. Join thought leaders from industry, legal, public affairs, and government for interactive and compelling discussions that will shape policy and define strategic priorities within the advertising and promotion regulatory space.
This conference is geared towards both early and late-career professionals with content that advances the understanding of current regulatory policies, details the latest strategies for effective patient engagement, and discusses the trends in advertising for medical products. You will have the opportunity to network with key thought leaders from the FDA, industry, and other regulatory practitioners, while simultaneously discussing the challenges and opportunities of marketing pharmaceuticals and medical devices today.
Avoid Unwanted Attention to Your Press Releases
Wednesday, February 2, 2022 | 12:00 – 1:00PM ET
This pre-event promotional webinar will address some of the issues companies are facing when developing press releases and why these communications can be challenging. The webinar will cover the historical regulation of Press Releases by the FDA’s Division of Drug Marketing, Advertising and Communications (DDMAC)/Office of Prescription Drug Promotion (OPDP), draw key concepts from previous FDA enforcement and illustrate principles to avoid FDA action. The webinar will also frame the key legal and regulatory considerations companies should be aware of when issuing Press Releases.
Want to learn more about Advertising and Promotion Regulatory Affairs Conference? You've come to the right site!
Short Course or Primer
To keep you at the forefront.
Micheline Awad, MBA Sr. Director, Regulatory Advertising, Promotion, and Labeling
Day One Biopharmaceuticals, United States
Sheetal Patel, PharmD Vice President, Specialty Compliance
Johnson & Johnson, United States
Fadwa Almanakly, PharmD Vice President & Head, Advertising and Promotion, Regulatory Affairs Americas
Bayer Pharmaceuticals, United States
Heather Banuelos, JD Counsel
King & Spalding LLP, United States
Kimberly Belsky, MS Reg Policy & Intell and AdPromo, Regulatory Affairs
Independent, United States
Bob Dean, MBA Head of Global Labeling Strategy & Ad/Promo
EMD Serono, United States
Virginia Foley Head of Marketing & Strategic Business Development Ad Promo - Practice Leader
Opus Regulatory Inc, United States
Catherine Gray, PharmD Director, Office of Prescription Drug Promotion, OMP, CDER
FDA, United States
Joanne Hawana, JD, MS Member
Mintz, Levin, Cohn, Ferris, Glovsky & Popeo P.C., United States
Dale Cooke, JD, MA President
PhillyCooke Consulting , United States
Georgina Lee, PharmD Executive Director, Regulatory Advertising and Promotion
Sage Therapeutics, United States
Mark Gaydos Global Head, Advertising & Promotion, Global Regulatory Affairs
Sanofi, United States
Wayne Pines President, Health Care
Lucy Rose, MBA President
Lucy Rose and Associates, United States
Have an account?